JBF Capital’s Twist Bioscience TWST Stock Holding History

JBF Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,100	Closed	-$1.04M	–	96
2025 Q3	$1.04M	Buy	+37,100	New	+$1.12M	0.15%	38

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

JBF Capital's TWST Position: Q4 2025 in Review

JBF Capital sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 37,100 shares — an estimated $1.04M sold.

JBF Capital first reported a position in TWST in Q3 2025 and held it in 1 quarter. The position peaked at $1.04M in Q3 2025. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

JBF Capital reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
JBF Capital sold 37,100 Twist Bioscience shares in Q4 2025, an estimated $1.04M.
JBF Capital first reported a position in Twist Bioscience in Q3 2025 and held it in 1 quarter.
JBF Capital's Twist Bioscience position peaked at $1.04M in Q3 2025.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on JBF Capital's 13F filing for Q4 2025, filed 12 Feb 2026.